These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31298230)

  • 1. Inactivation of myostatin by photo-oxygenation using catalyst-functionalized peptides.
    Okamoto H; Taniguchi A; Usami S; Taguchi A; Takayama K; Hayashi Y
    Chem Commun (Camb); 2019 Aug; 55(62):9108-9111. PubMed ID: 31298230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of functionalized peptides for efficient inhibition of myostatin by selective photooxygenation.
    Okamoto H; Taniguchi A; Usami S; Katsuyama M; Konno S; Taguchi A; Takayama K; Hayashi Y
    Org Biomol Chem; 2021 Jan; 19(1):199-207. PubMed ID: 33174572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of myostatin by photooxygenation using functionalized d-peptides.
    Okamoto H; Murano SA; Ikekawa K; Katsuyama M; Konno S; Taguchi A; Takayama K; Taniguchi A; Hayashi Y
    RSC Med Chem; 2023 Feb; 14(2):386-392. PubMed ID: 36846372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of N-Terminal Acylation on the Activity of Myostatin Inhibitory Peptides.
    Takayama K; Nakamura A; Rentier C; Mino Y; Asari T; Saga Y; Taguchi A; Yakushiji F; Hayashi Y
    ChemMedChem; 2016 Apr; 11(8):845-9. PubMed ID: 26954624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the minimum peptide from mouse myostatin prodomain for human myostatin inhibition.
    Takayama K; Noguchi Y; Aoki S; Takayama S; Yoshida M; Asari T; Yakushiji F; Nishimatsu S; Ohsawa Y; Itoh F; Negishi Y; Sunada Y; Hayashi Y
    J Med Chem; 2015 Feb; 58(3):1544-9. PubMed ID: 25569186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic Stability of Myostatin Inhibitory 16-mer Peptides.
    Takayama K; Odagiri M; Taguchi A; Taniguchi A; Hayashi Y
    Chem Pharm Bull (Tokyo); 2020; 68(6):512-515. PubMed ID: 32475853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategic structure-activity relationship study on a follistatin-derived myostatin inhibitory peptide.
    Saitoh M; Takayama K; Roppongi Y; Shimada T; Taguchi A; Taniguchi A; Hayashi Y
    Bioorg Med Chem Lett; 2021 Aug; 46():128163. PubMed ID: 34087433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposal for the binding mode of the 23-mer inhibitory peptide to myostatin.
    Asari T; Ikeyama H; Taguchi A; Taniguchi A; Hayashi Y; Takayama K
    Bioorg Med Chem; 2021 Jun; 40():116181. PubMed ID: 33957441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amyloid-selective Photooxygenation toward Treatment for Amyloid Diseases].
    Taniguchi A
    Yakugaku Zasshi; 2018; 138(1):47-53. PubMed ID: 29311465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myostatin inhibitory region of fish (Paralichthys olivaceus) myostatin-1 propeptide.
    Lee SB; Kim JH; Jin DH; Jin HJ; Kim YS
    Comp Biochem Physiol B Biochem Mol Biol; 2016; 194-195():65-70. PubMed ID: 26827850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide Tool-Driven Functional Elucidation of Biomolecules Related to Endocrine System and Metabolism.
    Takayama K
    Chem Pharm Bull (Tokyo); 2022; 70(6):413-419. PubMed ID: 35650039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting myostatin for therapies against muscle-wasting disorders.
    Tsuchida K
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):487-94. PubMed ID: 18600566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Inhibitory Core of the Myostatin Prodomain: Its Interaction with Both Type I and II Membrane Receptors, and Potential to Treat Muscle Atrophy.
    Ohsawa Y; Takayama K; Nishimatsu S; Okada T; Fujino M; Fukai Y; Murakami T; Hagiwara H; Itoh F; Tsuchida K; Hayashi Y; Sunada Y
    PLoS One; 2015; 10(7):e0133713. PubMed ID: 26226340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of decorin derived peptides with a zinc dependent anti-myostatin activity.
    Guiraud S; van Wittenberghe L; Georger C; Scherman D; Kichler A
    Neuromuscul Disord; 2012 Dec; 22(12):1057-68. PubMed ID: 22854012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myostatin as a therapeutic target in Amyotrophic lateral sclerosis.
    Walsh FS; Rutkowski JL
    Neurochem Int; 2012 Nov; 61(6):931-5. PubMed ID: 22841860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Basis for the Effective Myostatin Inhibition of the Mouse Myostatin Prodomain-Derived Minimum Peptide.
    Asari T; Takayama K; Nakamura A; Shimada T; Taguchi A; Hayashi Y
    ACS Med Chem Lett; 2017 Jan; 8(1):113-117. PubMed ID: 28105285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrodynamic limb vein injection of adeno-associated virus serotype 8 vector carrying canine myostatin propeptide gene into normal dogs enhances muscle growth.
    Qiao C; Li J; Zheng H; Bogan J; Li J; Yuan Z; Zhang C; Bogan D; Kornegay J; Xiao X
    Hum Gene Ther; 2009 Jan; 20(1):1-10. PubMed ID: 18828709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organic chemistry: Light opens pathways for nickel catalysis.
    Murphy JJ; Melchiorre P
    Nature; 2015 Aug; 524(7565):297-8. PubMed ID: 26266981
    [No Abstract]   [Full Text] [Related]  

  • 19. A hybrid adsorbent/visible light photocatalyst for the abatement of microcystin-LR in water.
    Długosz M; Kwiecień A; Żmudzki P; Bober B; Krzek J; Bialczyk J; Nowakowska M; Szczubiałka K
    Chem Commun (Camb); 2015 May; 51(36):7649-52. PubMed ID: 25846369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and absolute configuration assignment of albucidin: a late-stage reductive deiodination by visible light photocatalysis.
    Zhang H; Liu PF; Chen Q; Wu QY; Seville A; Gu YC; Clough J; Zhou SL; Yang GF
    Org Biomol Chem; 2016 Apr; 14(13):3482-5. PubMed ID: 26972382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.